|
Index of reports
> Hospitalization (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prandin (Repaglinide) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Prandin side effects in 77 year old female
Reported by a consumer/non-health professional from United States on 2012-04-16
Patient: 77 year old female, weighing 96.1 kg (211.5 pounds)
Reactions: Hypoacusis, Cardiac Arrest
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prandin
Other drugs received by patient: Atorvastatin; Clonidine
Possible Prandin side effects in female
Reported by a physician from Korea, Republic of on 2012-03-20
Patient: female, weighing 46.1 kg (101.4 pounds)
Reactions: Hydronephrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 1.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-02-17
Prandin
Dosage: 6 mg, bid
Administration route: Oral
Indication: Immunosuppression
Start date: 2012-01-22
Sandimmune
Dosage: 175 mg, qd
Administration route: Oral
Indication: Immunosuppression
Start date: 2012-01-17
Possible Prandin side effects in
Reported by a consumer/non-health professional from United States on 2011-12-23
Patient:
Reactions: Surgery, Disturbance in Attention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Glipizide
Indication: Product Used FOR Unknown Indication
Prandin
Indication: Product Used FOR Unknown Indication
Victoza
Indication: Product Used FOR Unknown Indication
|
